It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Obviously a cancerous cell needs glucose to replicate. So do all of our cells.
Obviously a cancerous cell needs glucose to replicate. So do all of our cells.
More probable is that cancer cells shut down production in the mitochondria, which forces the cell to produce energy anaerobically. The reason they might do this is because mitochondria play a key role in cell induced death (apoptosis) - shut the mitochondria down, you stop the cell from killing itself in response to damage or other metabolic shifts.
About PSL-001:
PSL-001 is part of a patent portfolio fully and exclusively licensed from Johns Hopkins University by PreScience. PSL-001 is one of a new class of drugs that targets the tumor glycolysis pathway. This pathway is a signature of cancer cells and is considered one of the hallmarks of cancer. Tumor glycolysis has been exploited for diagnostic purposes (PET imaging) and is now being explored for therapeutic intervention. One of the key enzymes in tumor glycolysis, GAPDH, is the primary target of PSL-001. PSL-001 irreversibly binds to GAPDH resulting in a multi-prong assault on cancer cells, ultimately leading to their death. The predominant effect of this interaction is the profound depletion of ATP, depriving the cancer cells of any energy. Because glycolysis is the dominant metabolic pathway in cancer cells, those cells are acutely sensitive to any disruption of that pathway. In addition, because normal cells do not rely on glycolysis, but rather on oxidative phosphorylation for their energy needs, disruption of glycolysis is highly specific to cancer cells. The combination of high sensitivity and specificity makes targeting tumor glycolysis highly attractive. Through its ability to inhibit GAPDH, PSL-001 has proven extremely effective at shutting down the energy-producing capabilities of cancer cells which in turn destroys them. PreScience’s core technology and patent protection relies on both the novel PSL-001 compound and the targeted regional delivery of the drug, thereby treating only the cancer. PSL-001 will be further evaluated in a PreScience sponsored Phase I study to begin enrollment in early-2014.
originally posted by: PeterMcFly
Johns Hopkins University experiment on PSL-001 seem to strongly confirm what I'm saying about glucose starvation of cancerous cells and the Warburg hypothesis on the cause(s) of cancer.
PreScience Labs Announced that the FDA Accepts IND Application for Novel Oncology Drug
About PSL-001:
PSL-001 is part of a patent portfolio fully and exclusively licensed from Johns Hopkins University by PreScience. PSL-001 is one of a new class of drugs that targets the tumor glycolysis pathway. This pathway is a signature of cancer cells and is considered one of the hallmarks of cancer. Tumor glycolysis has been exploited for diagnostic purposes (PET imaging) and is now being explored for therapeutic intervention. One of the key enzymes in tumor glycolysis, GAPDH, is the primary target of PSL-001. PSL-001 irreversibly binds to GAPDH resulting in a multi-prong assault on cancer cells, ultimately leading to their death. The predominant effect of this interaction is the profound depletion of ATP, depriving the cancer cells of any energy. Because glycolysis is the dominant metabolic pathway in cancer cells, those cells are acutely sensitive to any disruption of that pathway. In addition, because normal cells do not rely on glycolysis, but rather on oxidative phosphorylation for their energy needs, disruption of glycolysis is highly specific to cancer cells. The combination of high sensitivity and specificity makes targeting tumor glycolysis highly attractive. Through its ability to inhibit GAPDH, PSL-001 has proven extremely effective at shutting down the energy-producing capabilities of cancer cells which in turn destroys them. PreScience’s core technology and patent protection relies on both the novel PSL-001 compound and the targeted regional delivery of the drug, thereby treating only the cancer. PSL-001 will be further evaluated in a PreScience sponsored Phase I study to begin enrollment in early-2014.
Bromopyruvic acid
Glyceraldehyde 3-phosphate dehydrogenase
Always much more profitable to patent a drug than a non-lucrative simple ketogenic diet.
Being a hallmark of cancer does not make you a cause of cancer. Please see my previous post on this.
Anoxic regeneration of NADH is only an effective means of energy production during short, intense exercise, providing energy for a period ranging from 10 seconds to 2 minutes and is dominant from about 10–30 seconds during a maximal effort. It replenishes very quickly over this period and produces 2 ATP molecules per glucose molecule, or about 5% of glucose's energy potential (38 ATP molecules in bacteria). The speed at which ATP is produced is about 100 times that of oxidative phosphorylation. The pH in the cytoplasm quickly drops when hydrogen ions accumulate in the muscle, eventually inhibiting enzymes involved in glycolysis.
Ketone bodies are an alternative to glucose as a supplier of the metabolic energy needs for brain. Cahill has shown [51] that during prolonged fasting, when total blood ketone bodies are in the 5– 7 mM range, blood glucose concentrations can be decreased to below 1 mM (18 mg/dL) without either convulsions or any discernable impairment of cognitive function. At these concentrations, ketone bodies can provide essentially all of the energy demands in brain to maintain function. The induction of mild ketosis therefore offers a method for obtaining tighter control of blood glucose in brittle diabetics without the induction of the physiological consequences of hypoglycemia on cerebral function.
originally posted by: bigfatfurrytexan
the best example of a high carb diet: Fois Gras
Humans get fatty liver, too. Especially drinkers.
Carbohydrates are meant to be a seasonal food for those of us hailing from the north. I do terrible eating carbs. It effects my health poorly in multiple ways.